Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy Interventions: Drug: Canagliflozin; Drug: Placebo Sponsor: Mitsubishi Tanabe Pharma Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2018 Category: Research Source Type: clinical trials
